Citations

Clear

4847 citation(s) found for "Yu, Eric".

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
Tjin, Gavin , White, Eric S. , Faiz, Alen , Tschumperlin, Daniel J. , Mahar, Annabelle , Kable, Eleanor , Burgess, Janette K. , Sicard, Delphine , Tjin, Gavin , Sicard, Delphine , Tschumperlin, Daniel J , Mahar, Annabelle , Kable, Eleanor P W , Burgess, Janette K , White, Eric S , Tjin, Gavin

Mayo Clinic

Disease Models & Mechanisms | November 6, 2017 | Volume: 10 | Issue: 11 | Pages: 1301-1312

10.1242/dmm.030114 | PMID 29125826 Get It

ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with few effective therapeutic options. Structural remodelling of the extracellular matrix [i.e. collagen cross-linking mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1-4)] might contribute to disease pathogenesis and represent a therapeutic target. This study aimed to further our understanding of the mechanisms by which LO inhibitors might improve lung fibrosis. Lung tissues from IPF and non-IPF subjects were examined for collagen structure (second harmonic generation imaging) and LO gene (microarray analysis) and protein (immunohistochemistry and western blotting) levels. Functional effects (collagen structure and tissue stiffness using atomic force microscopy) of LO inhibitors on collagen remodelling were examined in two models, collagen hydrogels and decellularized human lung matrices. LOXL1/LOXL2 gene expression and protein levels were increased in IPF versus non-IPF. Increased collagen fibril thickness in IPF versus non-IPF lung tissues correlated with increased LOXL1/LOXL2, and decreased LOX, protein expression. β-Aminoproprionitrile (β-APN; pan-LO inhibitor) but not Compound A (LOXL2-specific inhibitor) interfered with transforming growth factor-β-induced collagen remodelling in both models. The β-APN treatment group was tested further, and β-APN was found to interfere with stiffening in the decellularized matrix model. LOXL1 activity might drive collagen remodelling in IPF lungs. The interrelationship between collagen structural remodelling and LOs is disrupted in IPF lungs. Inhibition of LO activity alleviates fibrosis by limiting fibrillar collagen cross-linking, thereby potentially impeding the formation of a pathological microenvironment in IPF.
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
Magvanjav, Oyunbileg , McDonough, Caitrin W. , Chapman, Arlene B. , Gums, John G. , Bailey, Kent R. , Boerwinkle, Eric , Beitelshees, Amber L. , Kubo, Michiaki , Pepine, Carl J. , Johnson, Julie A. , Beitelshees, Amber L. , Turner, Stephen T. , Gong, Yan , Tanaka, Toshihiro , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

Journal of the American Heart Association | November 3, 2017 | Volume: 6 | Issue: 11 | Pages: No page available

10.1161/jaha.117.006522 | PMID 29097388 Get It

Background The majority of hypertensive individuals require combination antihypertensive therapy to achieve adequate blood pressure ( BP ) control. This study aimed to identify genetic variants associated with uncontrolled BP on combination therapy with a thiazide diuretic and a β‐blocker. Methods and Results A genome‐wide association study of uncontrolled BP on combination therapy was conducted among 314 white participants of the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) trial. Multivariable logistic regression analysis was used. Genetic variants meeting a suggestive level of significance ( P <1.0E‐05) were tested for replication in an external cohort, INVEST (International Verapamil‐ SR Trandolapril study). We also examined genome‐wide variant associations with systolic and diastolic BP response on combination therapy and tested for replication. We discovered a single nucleotide polymorphism, the rs261316 major allele, at chromosome 15 in the gene ALDH1A2 associated with an increased odds of having uncontrolled BP on combination therapy (odds ratio: 2.56, 95% confidence interval, 1.69–3.88, P =8.64E‐06). This single nucleotide polymorphism replicated (odds ratio: 1.86, 95% confidence interval, 1.35–2.57, P =0.001) and approached genome‐wide significance in the meta‐analysis between discovery and replication cohorts (odds ratio: 2.16, 95% confidence interval, 1.63–2.86, P =8.60E‐08). Other genes in the region surrounding rs261316 ( ALDH1A2) include AQP9 and LIPC . Conclusions A single nucleotide polymorphism in the gene ALDH1A2 may be associated with uncontrolled BP following treatment with a thiazide diuretic/β‐blocker combination. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT 00246519.
Rates and Locations of Regional Metastases in Sinonasal Malignancies: The Mayo Clinic Experience
Peck, Brandon W., Abel, Kathryn M. Van , Moore, Eric J. , Van Abel, Kathryn M, Van Abel, Kathryn M , Price, Daniel L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | November 1, 2017 | Volume: 79 | Issue: 03 | Pages: 282-288

10.1055/s-0037-1607288 | PMID 29765826 Get It

Objectives The objective of this study was to identify factors that may influence the rate and location of regional metastasis in sinonasal malignancies (SNMs). Design This is a retrospective review. Setting This study was set at the single-institution tertiary referral center. Participants A total of 299 patients were treated for SNMs from 1994 to 2014. Main Outcome Measures The main outcome measures were incidence and distribution of regional metastases. Results Several histologic subtypes were treated, with squamous cell carcinoma (28.4%), esthesioneuroblastoma (18.1%), and mucosal melanoma (12.4%) being the most common. Of the 299 patients, 59 (19.7%) developed a regional metastasis, either at presentation or during follow-up. Higher cumulative incidence of regional metastases was significantly associated with histologic type (p ≤0.001) and invasion of the dura (p = 0.005), infratemporal fossa (p = 0.036), orbit (p = 0.020), or palate (p = 0.016). Ipsilateral level II lymph nodes were the most commonly involved nodes. Contralateral regional metastases were associated with higher risk histologic types (p = 0.005) and dural invasion (p = 0.008). Parotid metastases were associated with invasion of the facial soft tissue (p = 0.028), and retropharyngeal metastases were associated with invasion of the pterygoid plates and musculature (p = 0.030). Conclusion Histologic type of SNM appears to be the most important factor in predicting the rate of regional metastases. Histologic type and invasion of certain neighboring structures may help define which lymphatic basins are at highest risk for metastasis.
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases
Allen, Mariet , Wang, Xue , Burgess, Jeremy D. , Serie, Daniel, Younkin, Curtis, Nguyen, Thuy , Malphrus, Kimberly G., Lincoln, Sarah, Carrasquillo, Minerva M. , Ho, Charlotte C.G. , Chakrabarty, Paramita , Strickland, Samantha L. , Murray, Melissa E. , Geschwind, Daniel H. , Seyfried, Nicholas T. , Dammer, Eric B. , Levey, Allan I. , Golde, Todd E. , Funk, Cory C. , Li, Hongdong , Price, Nathan D. , Petersen, Ronald C. , Graff‐Radford, Neill R. , Younkin, Steven G. , Crook, Julia, Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Watzlawik, Jens, Serie, Daniel J, Younkin, Curtis S, Ho, Charlotte, Crook, Julia R, Price, Nathan D , Murray, Melissa E , Watzlawik, Jens O. , Carrasquillo, Minerva M. , Swarup, Vivek , Lah, James J. , Li, Hongdong, Dickson, Dennis W. , Dammer, Eric B , Levey, Allan I

Mayo Clinic

Alzheimer's & Dementia | October 31, 2017 | Volume: 14 | Issue: 3 | Pages: 352-366

10.1016/j.jalz.2017.09.012 | PMID 29107053 Get It

Abstract Introduction Comparative transcriptome analyses in Alzheimer's disease (AD) and other neurodegenerative proteinopathies can uncover both shared and distinct disease pathways. Methods We analyzed 940 brain transcriptomes including patients with AD, progressive supranuclear palsy (PSP; a primary tauopathy), and control subjects. Results We identified transcriptional coexpression networks implicated in myelination, which were lower in PSP temporal cortex (TCX) compared with AD. Some of these associations were retained even after adjustments for brain cell population changes. These TCX myelination network structures were preserved in cerebellum but they were not differentially expressed in cerebellum between AD and PSP. Myelination networks were downregulated in both AD and PSP, when compared with control TCX samples. Discussion Downregulation of myelination networks may underlie both PSP and AD pathophysiology, but may be more pronounced in PSP. These data also highlight conservation of transcriptional networks across brain regions and the influence of cell type changes on these networks.
Cognitive impairment in progressive supranuclear palsy is associated with tau burden
Koga, Shunsuke , Parks, Adam , Kasanuki, Koji , Josephs, Keith A. , Ahlskog, J. Eric , Uitti, Ryan J. , Graff‐Radford, Neill R. , Gerpen, Jay A. van, Rademakers, Rosa , Baker, Matthew C, Van Gerpen, Jay A, Koga, Shunsuke , Sánchez-Contreras, Mónica , Baker, Matthew , Wszołek, Zbigniew K. , Dickson, Dennis W.

Mayo Clinic

Movement Disorders | October 30, 2017 | Volume: 32 | Issue: 12 | Pages: 1772-1779

10.1002/mds.27198 | PMID 29082658 Get It

Abstract Background Cognitive impairment is one of the core features of progressive supranuclear palsy. This study aimed to clarify the profile of cognitive impairment and its underlying pathology in progressive supranuclear palsy. Methods We retrospectively reviewed medical records to evaluate the pattern and severity of cognitive impairment in 121 autopsy‐confirmed progressive supranuclear palsy patients. A subset of 37 patients underwent neuropsychological evaluation as part of their clinical workup. The burden of progressive supranuclear palsy‐related tau pathology (neurofibrillary tangles/pretangles, coiled bodies, tufted astrocytes, and threads) was semiquantitatively scored in 20 vulnerable brain regions. Concurrent pathologies potentially associated with cognitive impairment, such as Alzheimer's‐type pathology, were also assessed. To evaluate possible genetic risk factors for cognitive impairment, genetic analysis for APOE and MAPT was performed. Results Ninety patients (74%) had documented cognitive impairment based on neurologic evaluation. In a subgroup with neuropsychological testing (n = 37), executive functioning was the most severely impaired cognitive domain. A global cognitive impairment index (Spearman's rho, −0.49; P = 0.005) and executive functioning were negatively correlated with total tau burden (Spearman's rho, −0.51; P = 0.003), but not correlated with the Alzheimer's‐type pathology. APOE ɛ4 carriers had more severe amyloid pathology, but total tau burden and a global cognitive impairment index did not differ from APOE ɛ4 noncarriers. Conclusion Cognitive impairment in progressive supranuclear palsy, most notably executive dysfunction, is associated with severity of progressive supranuclear palsy‐related tau pathology. © 2017 International Parkinson and Movement Disorder Society
Large-vessel giant cell arteritis: diagnosis, monitoring and management
Matteson, Eric L. , Warrington, Kenneth J. , Warrington, Kenneth J , Koster, Matthew J.

Mayo Clinic

Rheumatology | October 28, 2017 | Volume: 57 | Issue: suppl_2 | Pages: ii32-ii42

10.1093/rheumatology/kex424 | PMID 29982778 Get It

Bone Grafting for Scaphoid Nonunions: Is Free Vascularized Bone Grafting Superior for Scaphoid Nonunion?
Aibinder, William R. , Wagner, Eric R. , Wagner, Eric R , Bishop, Allen T. , Shin, Alexander Y. , Aibinder, William R

Mayo Clinic

HAND | October 28, 2017 | Volume: 14 | Issue: 2 | Pages: 217-222

10.1177/1558944717736397 | PMID 29078719 Get It

Background: Nonvascularized bone grafting (NVBG) and vascularized bone grafts (VBGs) have been used to treat scaphoid nonunions. A comparison of a single institution’ s experience using structural iliac crest bone graft (ICBG), 1,2-intercompartmental supraretinacular artery (1,2-ICSRA), and medial femoral condyle (MFC) grafts to treat scaphoid nonunions was undertaken. Methods: Thirty-one patients underwent ICBG, 33 patients underwent 1,2-ICSRA, and 45 patients underwent MFC grafting. Mean time to follow-up was 16 months (range, 2-153). Twenty-three percent used tobacco products. Mean age was 24 years (range, 11-66), with 86% male patients. Outcomes included union rate, time to healing, range of motion, complications, and reoperations. Results: Union rates and mean time to union were 71% and 19 weeks for the ICBG group, 79% and 26 weeks for the 1,2-ICSRA group, and 89% and 16 weeks for the MFC group, respectively. Failure of union was associated with tobacco use but not with age, gender, time from injury to surgery, or type of fixation. There was no significant difference between the groups regarding range of motion or strength. Conclusions: These findings demonstrate the need for careful patient selection. In patients with the most complicated scaphoid nonunions (avascular necrosis, carpal collapse, and previous surgeries), the MFC group had the highest union rate and fastest time to union. Patients with risk factors for failure should be counseled on the outcomes and possible need for salvage fusion surgery.
The Ethnopharmacologic Contribution to Bioprospecting Natural Products
Buenz, Eric J. , Bauer, Brent A. , Verpoorte, Robert

Mayo Clinic

Annual Review of Pharmacology and Toxicology | October 27, 2017 | Volume: 58 | Issue: 1 | Pages: 509-530

10.1146/annurev-pharmtox-010617-052703 | PMID 29077533 Get It

Descriptions of the use of natural products in traditional medicine have served as starting points for new therapeutics. The details of the traditional use of these organisms can provide important information for future drug discovery and development efforts. Recent technologic advances provide the framework to leverage ethnopharmacologic data in the drug discovery process. Information on the traditional harvest, preparation, storage, and administration of the organisms, and the natural products they contain, provides valuable details regarding characteristics of the active compounds. Importantly, researchers can now rapidly analyze and identify the multiple, and often synergistic, compounds contained in these natural products. Although we are entering the acme of ethnopharmacology, where information regarding the traditional use of organisms can provide valuable natural product leads and accelerate the identification of new therapeutics, this ethnopharmacologic resource is threatened by the loss of traditional medicine knowledge and extinction of organisms.
Alveolar air and oxidative metabolic demand during exercise in healthy adults: the role of single-nucleotide polymorphisms of the β 2 AR gene
Iterson, Erik H. Van , Snyder, Eric M., Johnson, Bruce D., Van Iterson, Erik H

Mayo Clinic

Physiological Reports | October 23, 2017 | Volume: 5 | Issue: 20 | Pages: e13476

10.14814/phy2.13476 | PMID 29061864 Get It